Revolutionizing Parkinson’s Disease Treatment: TreeFrog Therapeutics’ Leap Forward
In the ever-evolving field of regenerative medicine, a significant milestone is on the horizon, courtesy of TreeFrog Therapeutics. At the 23rd Congress of the Japanese Society for Regenerative Medicine (JSRM) in Niigata, Japan, a presentation by Maxime Feyeux, the Chief Scientific Officer and Co-founder of TreeFrog, has sparked excitement and hope. TreeFrog Therapeutics, a frontrunner […]
BREAKTHROUGH TECHNOLOGY FOR IPS-DERIVED CELL THERAPIES TURNED INTO GMP PLATFORM BY TREEFROG THERAPEUTICS & INVETECH
BORDEAUX, France, Oct. 11, 2022 /PRNewswire/ — TreeFrog Therapeutics, a biotechnology company developing stem cell-derived therapies in regenerative medicine and immuno-oncology based on the biomimetic C-Stem™ technology platform, and Invetech, a global leader in the development and production of automated manufacturing solutions for cell and advanced therapies, today announced the delivery of a GMP-grade cell encapsulation device using the C-Stem™ technology. […]